A detailed history of Tejara Capital LTD transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 203,145 shares of STRO stock, worth $660,221. This represents 0.22% of its overall portfolio holdings.

Number of Shares
203,145
Previous 194,418 4.49%
Holding current value
$660,221
Previous $1.1 Billion 45.81%
% of portfolio
0.22%
Previous 0.4%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.92 - $5.33 $25,482 - $46,514
8,727 Added 4.49%
203,145 $595 Million
Q1 2024

May 14, 2024

SELL
$3.27 - $5.65 $106,389 - $183,822
-32,535 Reduced 14.34%
194,418 $1.1 Billion
Q4 2023

Feb 12, 2024

BUY
$2.07 - $4.54 $286,220 - $627,750
138,271 Added 155.92%
226,953 $974 Million
Q2 2023

Aug 11, 2023

BUY
$4.25 - $5.88 $187,845 - $259,890
44,199 Added 99.36%
88,682 $412 Million
Q1 2023

May 12, 2023

BUY
$4.48 - $8.45 $199,283 - $375,881
44,483 New
44,483 $206 Million

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $170M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.